Search the webpage

Created by Giedrius Kalesnykas on  January 27, 2020  in category: News

Kuopio, Finland, 27th January 2019: Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Guillaume Demarne, Pharm.D. to Director of Business Development.

Dr. Demarne received his Pharm.D. from Aix-Marseille University, France. He holds an Advanced Master from EM Lyon Business School and was trained in entrepreneurship and intercultural management at East China Normal University, Shanghai.

Prior to joining Experimentica Ltd., Dr. Demarne held several pharmaceutical Business Development positions in France, the United States, and China. Most recently, he served for three years as Chief Business Development Officer at Balmes Transplantation SAS, an early stage pharmaceutical company focused on the prevention of organ ischemia-reperfusion injuries.

Dr. Giedrius Kalesnykas, President and CEO of Experimentica Ltd., commented: “Over the past five years, we have substantially grown our presence on North American and European markets. As we are focusing on our global presence as an established and trusted partner in preclinical ophthalmic drug discovery, we were looking for a candidate with a deep understanding of global business development, especially in Asia, and a strong background in the biotech industry.

We are delighted that Dr. Demarne decided to join our team and lead our business development globally. He is an outstanding appointment for Experimentica in times when we aim to strengthen our business development in Southern Europe and Asia.”

About Experimentica Ltd.
Experimentica Ltd. is a preclinical contract research organization (CRO) dedicated to develop and provide ocular disease models. Relying entirely on in-house expertise, Experimentica Ltd. pursues Scientific Excellence in Ocular Models.

Experimentica Ltd. is headquartered in Kuopio, Finland with offices in Tampere, Finland, Forest Park, IL, USA, Shanghai, China, and an R&D site in Vilnius, Lithuania. For more information, visit www.experimentica.com.

Media enquiries:
Giedrius Kalesnykas, Ph.D.,
President and Chief Executive Officer
Phone: +358 (40) 930-7087
US Toll Free: +1 (844) 393-4393
Email: info@experimentica.com

LATEST NEWS

Experimentica Ltd. appoints new Director of Business Development

News
Kuopio, Finland, 27th January 2019: Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Guillaume ... Read More

Professional Development Programme at Experimentica in 2020

News
We are delighted to announce that professional development of our talented employees in 2020 will be co-funded by the European ... Read More

Meet us at SMi’s Ophthalmic Drugs Conference 2019 in London, UK, 2019

News
We are pleased to be a part of the 3rd Annual Ophthalmic Drugs Conference and Focus Day, taking place on ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!